Letter to the Editor Comment on: Opioid-sparing utility of subcutaneous analgesia systems in pediatric oncology patients following major tumor resection surgery: A matched case-control study

We read with great interest the matched case control analysis by Tham and colleagues evaluating subcutaneous analgesic systems (SAS) in pediatric oncology resections (1). Focused matching by age and incision site and standardized conversion to oral morphine equivalent daily dose provide a clinically relevant framework for comparing postoperative opioid exposure. The topic is timely given the need for opioid minimization in vulnerable pediatric populations.